Araldi Gian Luca

Araldi Gian Luca is a sole proprietorship registered in SAM.gov, operating as a for-profit organization specializing in scientific consulting services within the pharmaceutical and neuroscience research domains. Registered since December 26, 2013, with a current registration valid through August 25, 2026, the company provides high-level scientific consulting to various federal agencies, particularly within the National Institutes of Health (NIH) ecosystem. While limited publicly available background information exists, the company appears to be led by Dr. Gian Luca Araldi, who leverages extensive scientific expertise to support complex research and development initiatives.

The company has consistently secured federal contract awards from the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Drug Abuse (NIDA), focusing on specialized consulting services in pharmaceutical research. These contracts, all designated as total small business set-asides, have included medicinal chemistry consulting, process chemistry consulting, pharmaceutics formulation, and chemistry manufacturing and controls (CMC) consulting for small molecules and biologics. Recent contract awards range from $8,460 to $568,500, supporting critical NIH programs such as the Blueprint Neurotherapeutics Network, Helping to End Addiction Long-term (HEAL) Initiative, and neuroscience drug discovery efforts. The contracts are typically structured as purchase orders with performance periods ranging from one to three years, requiring key personnel with advanced scientific degrees and substantial industry experience in drug development, process chemistry, and related scientific domains.